Researchers ID potential patient population who may benefit from novel anti-platelet treatment
Prasugrel, a novel anti-platelet therapy, is used to prevent recurrent cardiovascular events in patients who have had a prior heart attack, suffer severe chest pain and have been treated with coronary artery procedures (revascularization).
Oct 24, 2012
0
0